Soru

Zorluk: ZorInterpreting Laboratory Results

An infectious disease specialist is reviewing the laboratory data of five adult patients referred to an ambulatory clinic for evaluation of potential liver disease. Vital signs are within normal limits for all patients. Reference ranges for the hepatic panel are as follows: AST 8−408-40 U/L, ALT 7−567-56 U/L, Total Bilirubin 0.1−1.20.1-1.2 mg/dL. Match each patient's comprehensive biochemical and serological laboratory profile to the most accurate diagnostic interpretation.

  • Profile A: AST 1818 U/L, ALT 2222 U/L. Serology: HBsAg (-), Anti-HBs (+), Total Anti-HBc (-), Anti-HBc IgM (-)Immunity mediated by isolated surface antibody production (Vaccination)
  • Profile B: AST 2020 U/L, ALT 1919 U/L. Serology: HBsAg (-), Anti-HBs (+), Total Anti-HBc (+), Anti-HBc IgM (-)Immunity with cleared viral load following natural exposure (Resolved infection)
  • Profile C: AST 850850 U/L, ALT 10501050 U/L, Total Bilirubin 4.24.2 mg/dL. Serology: HBsAg (+), Anti-HBs (-), Total Anti-HBc (+), Anti-HBc IgM (+)Active viral replication with robust acute hepatocellular injury (Acute infection)
  • Profile D: AST 450450 U/L, ALT 520520 U/L, Total Bilirubin 2.82.8 mg/dL. Serology: HBsAg (-), Anti-HBs (-), Total Anti-HBc (+), Anti-HBc IgM (+)Core-antibody dominant phase following surface antigen clearance (Window period)
  • Profile E: AST 6565 U/L, ALT 7878 U/L, Total Bilirubin 1.01.0 mg/dL. Serology: HBsAg (+), Anti-HBs (-), Total Anti-HBc (+), Anti-HBc IgM (-)Persistent viral presence with mild ongoing hepatocellular inflammation (Chronic infection)

Cevap

Profile A matches Vaccination; Profile B matches Resolved infection; Profile C matches Acute infection; Profile D matches the Window period; Profile E matches Chronic infection.
Each laboratory profile distinctly maps to a specific phase of Hepatitis B immunity or infection, driven by the presence or absence of specific surface and core antigens/antibodies over time, corroborated by the degree of hepatocellular injury (transaminase levels).

Adım Adım Çözüm

1
Analyze the surface antigen (HBsAg) and surface antibody (Anti-HBs) status.
Positive HBsAg indicates current active viral presence (Profiles C and E). Positive Anti-HBs indicates immunity (Profiles A and B). Negative for both suggests the window period (Profile D).
These are the primary markers for active viral presence versus long-term immunity.
2
Evaluate the core antibodies (Total Anti-HBc and Anti-HBc IgM).
Positive Total Anti-HBc indicates natural viral exposure (Profiles B, C, D, E), differentiating them from vaccination (Profile A). Positive IgM indicates recent/acute exposure (Profiles C and D).
Core antibodies reliably distinguish isolated recombinant vaccination from natural whole-virus infection and separate acute from chronic states.
3
Correlate the serology findings with hepatic transaminases and bilirubin levels.
Marked elevations in AST/ALT align with an acute infection or the subsequent window period (Profiles C and D). Mild elevations align with chronic infection (Profile E). Normal levels align with established immunity (Profiles A and B).
Liver function tests reflect the degree of active hepatocellular injury, validating the timeline established by the serological markers.

Anahtar Kavram

Hepatitis B Serology Interpretation
Bu soruyu puanla